First Documented Case of HIV Transmission to Patient Using PrEP (Truvada)


According to an article in POZ, an individual contracted a multi-drug resistant strain of HIV while keeping to a daily dosage of  Truvada (tenofovir/emtricitabine), commonly known as PrEP (pre-exposure prophylaxis).  Researchers determined that it is indeed possible for individuals who follow a PrEP protocol can contract HIV when exposed to a virus that resists the drugs included in Truvada.

Go in depth at POZ.